NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The Department of Homeland Security is temporarily halting TSA PreCheck and Global Entry, two of the most widely used trusted-traveler programs in the United States, amid a partial government shutdown.Read More